Common Stock, Shares, Outstanding of Arcadia Biosciences, Inc. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Arcadia Biosciences, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • Arcadia Biosciences, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 1,367,429, a 0.18% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Arcadia Biosciences, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 1,367,429 +2,489 +0.18% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 1,367,040 +4,200 +0.31% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 1,367,040 +4,200 +0.31% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 1,364,940 +79,603 +6.2% 31 Dec 2024 10-Q 07 Nov 2025 2025 Q3
Q3 2024 1,364,940 +254,603 +23% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 1,362,840 +254,408 +23% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 1,362,840 +505,268 +59% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 1,285,337 +669,258 +109% 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q3 2023 1,110,337 -23,532,623 -95% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 1,108,432 -21,080,486 -95% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 857,572 -21,331,346 -96% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 616,079 +61,470 +11% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 24,642,960 +2,458,725 +11% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 22,188,918 +25,268 +0.11% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 22,188,918 +852,669 +4% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 554,609 -12,896,252 -96% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 22,184,235 +11,352,032 +105% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 22,163,650 +12,117,210 +121% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 21,336,249 +12,682,154 +147% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 13,450,861 +4,804,712 +56% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 10,832,203 +2,186,054 +25% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 10,046,440 +3,779,446 +60% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 8,654,095 +3,876,676 +81% 31 Mar 2020 10-Q 13 May 2020 2020 Q1
Q4 2019 8,646,149 +3,871,230 +81% 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 8,646,149 +3,871,230 +81% 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 6,266,994 +1,492,630 +31% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 4,777,419 +2,296,282 +93% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 4,774,919 +2,640,765 +124% 31 Dec 2018 10-K 25 Mar 2020 2019 FY
Q3 2018 4,774,919 -37,908,144 -89% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 4,774,364 -37,890,457 -89% 30 Jun 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 2,481,137 -40,183,684 -94% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 2,134,154 -90,230 -4.1% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 42,683,063 -1,796,204 -4% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 42,664,821 -1,730,187 -3.9% 30 Jun 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 42,664,821 -1,584,072 -3.6% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 2,224,384 -41,959,811 -95% 31 Dec 2016 10-K 20 Mar 2018 2017 FY
Q3 2016 44,479,267 +548,173 +1.2% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 44,395,008 +813,313 +1.9% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 44,248,893 +42,171,111 +2030% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 44,184,195 +42,110,165 +2030% 31 Dec 2015 10-K 08 Mar 2017 2016 FY
Q3 2015 43,931,094 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 43,581,695 30 Jun 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 2,077,782 31 Mar 2015 10-Q 25 Jun 2015 2015 Q1
Q4 2014 2,074,030 31 Dec 2014 10-K 08 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.